Living lipidic materials for enhanced probiotic formulations
A novel technology utilizing monoolein mesophase encapsulation to improve probiotic stability and bioavailability in foods and beverages. This formulation provides protection in acidic environments and controlled release in alkaline conditions, enhancing probiotic efficacy.
Overview
The innovative approach of using monoolein mesophase encapsulation offers a groundbreaking solution to enhance the stability and bioavailability of probiotics in food and beverage products. By encapsulating probiotics in a lipid-based matrix, the technology ensures protection in low pH environments and controlled release in higher pH conditions, thereby optimizing probiotic efficacy. This formulation can significantly improve the shelf-life and functional benefits of probiotic-enriched products, making it ideal for the food and beverage industry.
Technical specifications
Key features:
- Encapsulation in Monoolein Mesophase: Provides a protective nanostructure that regulates nutrient access and enhances probiotic survival.
- pH-Responsive Release: Tuned to protect probiotics in acidic environments and release them in alkaline conditions.
- Thermodynamic Stability: Can be formulated as a gel-like material or dispersed into particles for various applications.
- Comprehensive Characterization: Utilizes small angle X-ray scattering (SAXS) and cryoSEM to characterize materials, ensuring compatibility and effectiveness.
- Dynamic System Monitoring: Employs in vitro digestion studies to optimize release timing and phase transitions.
Technology readiness level
The technology is currently at TRL 3, having demonstrated proof of concept in laboratory settings. Future validation plans include further formulation tuning and extensive characterization to optimize the system for commercial applications. Partnership opportunities are available for joint development, offering potential collaborators a chance to engage with cutting-edge probiotic formulation technologies.
About Monash University, Melbourne
Monash University is a comprehensive public research university and one of Australia’s largest, known for scale, interdisciplinarity, and an applied orientation. Its Melbourne-based technology precinct brings together university laboratories, pilot-scale and prototyping suites, and company R&D groups alongside government research organizations to enable co-development and rapid iteration. Integration with a major hospital network supports clinical trials and translation, while structured industry placements and doctoral partnerships create a robust talent pipeline for corporate R&D. Research is backed by competitive funding from the Australian Research Council, the National Health and Medical Research Council, and state and federal programs that incentivize industry collaboration. A dedicated technology transfer office manages IP, licensing, and startup formation, with pathways to incubation and investment within the precinct.
delivered to your inbox.